Overview
Female breast cancer is a malignant neoplasm arising from the epithelial cells of the breast in women, most often originating in the ducts or lobules of the glandular tissue. It is the most frequently diagnosed cancer among women worldwide and is biologically heterogeneous, encompassing in-situ lesions such as ductal carcinoma in situ and invasive carcinomas that can spread to regional lymph nodes and distant organs. Tumours are classified by histological type and grade and by molecular features, including hormone-receptor and HER2 status, which together guide prognosis and the selection of surgery, radiotherapy, chemotherapy, endocrine therapy, and targeted agents. Risk reflects a combination of age, reproductive and hormonal history, family history and inherited mutations, and lifestyle and environmental factors. Early detection through breast awareness, clinical examination, and screening improves the likelihood of curative treatment and better survival, yet uptake of screening varies markedly across populations and settings. Outcomes are further shaped by stage at diagnosis, access to timely diagnostic pathology and treatment, and the broader health system. Beyond the disease itself, a diagnosis carries a substantial psychological burden, and survivorship is influenced by psycho-oncological care, supportive services, and attention to the social and cultural context in which women experience and manage the illness.
Research published in this journal
6 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Survival among Breast Cancer Patients in a Tertiary Cancer Center in Brunei Darussalam
Deficits in Psycho-Oncological Care among Turkish Immigrant Women with Breast Cancer in Germany – An Interview Study.
Uptake of Breast Screening Among Female Staff at A Tertiary Health Institution in South-West Nigeria
Epidemiology and the Histopathological Pattern of Diagnosis of Thyroid Diseases in a University Hospital in Riyadh, Saudi Arabia
Comparison of Phosphohistone H3 Immunohistochemical Staining, Ki-67, and H&E Mitotic Count in Invasive Breast Carcinoma
How this research is being cited
The 6 articles above have been cited 15 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Journal of Cancer Biology
-
2023 · Physikalische Medizin Rehabilitationsmedizin Kurortmedizin
-
2023 · Physikalische Medizin, Rehabilitationsmedizin, Kurortmedizin
-
Zahid Mahmood Akhtar et al. · 2022 · Pakistan Journal of Medical & Health Sciences
-
2022 · Texila international journal of public health
-
2022 · Texila international journal of public health
-
2022 ·
-
Dauda Bawa et al. · 2021 · International Journal of Surgery Research & Practice
A sample of recent works citing this journal's research on Female Breast Cancer, linking to each citing work.